Teladoc Health (NYSE:TDOC – Free Report) had its price target lowered by Canaccord Genuity Group from $28.00 to $25.00 in a report released on Friday, Benzinga reports. The brokerage currently has a buy rating on the health services provider’s stock. TDOC has been the subject of several other reports. Truist Financial reduced their target price […]